Industry Research Reports

Home > Reports > Chemical & Material > Reduced Glutathione (GSH) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Reduced Glutathione (GSH) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-05-25

Pages: 102 Pages

Report ld: 4745723

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Reduced Glutathione (GSH) Market Size(US$)

CAGR 2025-2031

3.5%

Market Size,2031

USD 184

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 149 million

Market Forecast in 2031(Value)

US$ 184 million

CAGR

3.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Reduced Glutathione (GSH) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Reduced Glutathione (GSH) is a tripeptide compound composed of glutamic acid, cysteine, and glycine, widely present in human cells and one of the most important antioxidants in the body. GSH plays multiple key roles within cells, including antioxidant activity, maintaining intracellular homeostasis, detoxification, and involvement in cell signaling. It neutralizes free radicals and protects cells from oxidative damage, which is crucial for maintaining normal cell function and health. In the medical field, Reduced Glutathione is used to treat various diseases, such as liver diseases, cardiovascular diseases, and neurological disorders, due to its significant effects in antioxidant and cell protection. With increasing research into health and antioxidants, the applications of Reduced Glutathione in nutritional supplements, cosmetics, and food additives are also expanding, making it an important subject in modern medicine and health.

Market Development Opportunities & Main Driving Factors

With increasing public attention to health, the market for Reduced Glutathione (GSH) has witnessed broad development opportunities. In the medical field, GSH is widely used to treat liver diseases, cardiovascular diseases, and neurological disorders due to its significant antioxidant and cell - protective effects. As population aging intensifies and the incidence of chronic diseases rises, the demand for GSH is also increasing. Additionally, in the nutritional supplement market, consumer demand for natural antioxidants continues to rise, and GSH, as an efficient antioxidant, is gaining favor with more consumers. In the cosmetics industry, GSH is also used in anti - aging products because it can neutralize free radicals, reduce skin oxidative damage, and delay skin aging. With technological progress and improvements in production processes, the production cost of GSH is gradually decreasing, making its application in more fields possible and further driving market growth.

Market Challenges, Risks, & Restraints

Despite its huge potential, the GSH market also faces some challenges and risks. First, product quality and stability are key issues. GSH is prone to oxidation during production and storage, affecting its bioactivity and efficacy. Therefore, companies need to strictly control the production process to ensure product quality. Secondly, market competition is becoming increasingly fierce, with more and more companies entering the field, leading to intensified competition for market share. Companies need to continuously enhance their competitiveness in product quality, price, brand, and sales channels to cope with intense market competition. Moreover, changes in regulations and policies also have a certain impact on the GSH market. The food and pharmaceutical industries are subject to strict regulatory oversight, and adjustments in regulations and policies may increase compliance costs for companies and even affect product production and sales.

Downstream Demand Trends

Looking at downstream demand, GSH has broad application prospects in multiple fields. In the medical field, with increasing attention to the treatment of chronic diseases and in - depth research into antioxidant therapies, the application of GSH in the treatment of liver diseases, cardiovascular diseases, and neurological disorders will be even broader. In the nutritional supplement market, as consumer attention to health and antioxidants continues to rise, the market demand for GSH as an efficient antioxidant will continue to grow. In the cosmetics industry, with increasing consumer demand for natural ingredients and anti - aging products, the application of GSH in high - end cosmetics will be further expanded. In the future, with increasing public attention to health and in - depth research into natural antioxidants, the application fields and market potential of GSH will be further expanded.

This report aims to provide a comprehensive presentation of the global market for Reduced Glutathione (GSH), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Reduced Glutathione (GSH) by region & country, by Type, and by Application.

The Reduced Glutathione (GSH) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reduced Glutathione (GSH).

MARKET SEGMENTATION

By Company

Kyowa Hakko Bio
Sigma-Aldrich
Cayman Chemical
Santa Cruz Biotechnology
Shandong Jincheng Biological Pharmaceutical
GSH World
Kaiping Genuine Biochemical Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Food Grade
Cosmetic Grade
Pharmaceutical Grade

Segment by Application

Pharmaceuticals
Food Industry
Health Care Products
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Reduced Glutathione (GSH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Reduced Glutathione (GSH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Reduced Glutathione (GSH) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Reduced Glutathione (GSH) Product Introduction

1.2 Global Reduced Glutathione (GSH) Market Size Forecast

1.2.1 Global Reduced Glutathione (GSH) Sales Value (2020-2031)

1.2.2 Global Reduced Glutathione (GSH) Sales Volume (2020-2031)

1.2.3 Global Reduced Glutathione (GSH) Sales Price (2020-2031)

1.3 Reduced Glutathione (GSH) Market Trends & Drivers

1.3.1 Reduced Glutathione (GSH) Industry Trends

1.3.2 Reduced Glutathione (GSH) Market Drivers & Opportunity

1.3.3 Reduced Glutathione (GSH) Market Challenges

1.3.4 Reduced Glutathione (GSH) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Reduced Glutathione (GSH) Players Revenue Ranking (2024)

2.2 Global Reduced Glutathione (GSH) Revenue by Company (2020-2025)

2.3 Global Reduced Glutathione (GSH) Players Sales Volume Ranking (2024)

2.4 Global Reduced Glutathione (GSH) Sales Volume by Company Players (2020-2025)

2.5 Global Reduced Glutathione (GSH) Average Price by Company (2020-2025)

2.6 Key Manufacturers Reduced Glutathione (GSH) Manufacturing Base and Headquarters

2.7 Key Manufacturers Reduced Glutathione (GSH) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Reduced Glutathione (GSH)

2.9 Reduced Glutathione (GSH) Market Competitive Analysis

2.9.1 Reduced Glutathione (GSH) Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Reduced Glutathione (GSH) Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reduced Glutathione (GSH) as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Food Grade

3.1.2 Cosmetic Grade

3.1.3 Pharmaceutical Grade

3.2 Global Reduced Glutathione (GSH) Sales Value by Type

3.2.1 Global Reduced Glutathione (GSH) Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Reduced Glutathione (GSH) Sales Value, by Type (2020-2031)

3.2.3 Global Reduced Glutathione (GSH) Sales Value, by Type (%) (2020-2031)

3.3 Global Reduced Glutathione (GSH) Sales Volume by Type

3.3.1 Global Reduced Glutathione (GSH) Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Reduced Glutathione (GSH) Sales Volume, by Type (2020-2031)

3.3.3 Global Reduced Glutathione (GSH) Sales Volume, by Type (%) (2020-2031)

3.4 Global Reduced Glutathione (GSH) Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceuticals

4.1.2 Food Industry

4.1.3 Health Care Products

4.1.4 Other

4.2 Global Reduced Glutathione (GSH) Sales Value by Application

4.2.1 Global Reduced Glutathione (GSH) Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Reduced Glutathione (GSH) Sales Value, by Application (2020-2031)

4.2.3 Global Reduced Glutathione (GSH) Sales Value, by Application (%) (2020-2031)

4.3 Global Reduced Glutathione (GSH) Sales Volume by Application

4.3.1 Global Reduced Glutathione (GSH) Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Reduced Glutathione (GSH) Sales Volume, by Application (2020-2031)

4.3.3 Global Reduced Glutathione (GSH) Sales Volume, by Application (%) (2020-2031)

4.4 Global Reduced Glutathione (GSH) Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Reduced Glutathione (GSH) Sales Value by Region

5.1.1 Global Reduced Glutathione (GSH) Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Reduced Glutathione (GSH) Sales Value by Region (2020-2025)

5.1.3 Global Reduced Glutathione (GSH) Sales Value by Region (2026-2031)

5.1.4 Global Reduced Glutathione (GSH) Sales Value by Region (%), (2020-2031)

5.2 Global Reduced Glutathione (GSH) Sales Volume by Region

5.2.1 Global Reduced Glutathione (GSH) Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Reduced Glutathione (GSH) Sales Volume by Region (2020-2025)

5.2.3 Global Reduced Glutathione (GSH) Sales Volume by Region (2026-2031)

5.2.4 Global Reduced Glutathione (GSH) Sales Volume by Region (%), (2020-2031)

5.3 Global Reduced Glutathione (GSH) Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Reduced Glutathione (GSH) Sales Value, 2020-2031

5.4.2 North America Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Reduced Glutathione (GSH) Sales Value, 2020-2031

5.5.2 Europe Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Reduced Glutathione (GSH) Sales Value, 2020-2031

5.6.2 Asia Pacific Reduced Glutathione (GSH) Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Reduced Glutathione (GSH) Sales Value, 2020-2031

5.7.2 South America Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Reduced Glutathione (GSH) Sales Value, 2020-2031

5.8.2 Middle East & Africa Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Reduced Glutathione (GSH) Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Reduced Glutathione (GSH) Sales Value and Sales Volume

6.2.1 Key Countries/Regions Reduced Glutathione (GSH) Sales Value, 2020-2031

6.2.2 Key Countries/Regions Reduced Glutathione (GSH) Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Reduced Glutathione (GSH) Sales Value, 2020-2031

6.3.2 United States Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Reduced Glutathione (GSH) Sales Value, 2020-2031

6.4.2 Europe Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Reduced Glutathione (GSH) Sales Value, 2020-2031

6.5.2 China Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.5.3 China Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Reduced Glutathione (GSH) Sales Value, 2020-2031

6.6.2 Japan Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Reduced Glutathione (GSH) Sales Value, 2020-2031

6.7.2 South Korea Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Reduced Glutathione (GSH) Sales Value, 2020-2031

6.8.2 Southeast Asia Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Reduced Glutathione (GSH) Sales Value, 2020-2031

6.9.2 India Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

6.9.3 India Reduced Glutathione (GSH) Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Kyowa Hakko Bio

7.1.1 Kyowa Hakko Bio Company Information

7.1.2 Kyowa Hakko Bio Introduction and Business Overview

7.1.3 Kyowa Hakko Bio Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Kyowa Hakko Bio Reduced Glutathione (GSH) Product Offerings

7.1.5 Kyowa Hakko Bio Recent Development

7.2 Sigma-Aldrich

7.2.1 Sigma-Aldrich Company Information

7.2.2 Sigma-Aldrich Introduction and Business Overview

7.2.3 Sigma-Aldrich Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Sigma-Aldrich Reduced Glutathione (GSH) Product Offerings

7.2.5 Sigma-Aldrich Recent Development

7.3 Cayman Chemical

7.3.1 Cayman Chemical Company Information

7.3.2 Cayman Chemical Introduction and Business Overview

7.3.3 Cayman Chemical Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Cayman Chemical Reduced Glutathione (GSH) Product Offerings

7.3.5 Cayman Chemical Recent Development

7.4 Santa Cruz Biotechnology

7.4.1 Santa Cruz Biotechnology Company Information

7.4.2 Santa Cruz Biotechnology Introduction and Business Overview

7.4.3 Santa Cruz Biotechnology Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Santa Cruz Biotechnology Reduced Glutathione (GSH) Product Offerings

7.4.5 Santa Cruz Biotechnology Recent Development

7.5 Shandong Jincheng Biological Pharmaceutical

7.5.1 Shandong Jincheng Biological Pharmaceutical Company Information

7.5.2 Shandong Jincheng Biological Pharmaceutical Introduction and Business Overview

7.5.3 Shandong Jincheng Biological Pharmaceutical Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Shandong Jincheng Biological Pharmaceutical Reduced Glutathione (GSH) Product Offerings

7.5.5 Shandong Jincheng Biological Pharmaceutical Recent Development

7.6 GSH World

7.6.1 GSH World Company Information

7.6.2 GSH World Introduction and Business Overview

7.6.3 GSH World Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 GSH World Reduced Glutathione (GSH) Product Offerings

7.6.5 GSH World Recent Development

7.7 Kaiping Genuine Biochemical Pharmaceutical

7.7.1 Kaiping Genuine Biochemical Pharmaceutical Company Information

7.7.2 Kaiping Genuine Biochemical Pharmaceutical Introduction and Business Overview

7.7.3 Kaiping Genuine Biochemical Pharmaceutical Reduced Glutathione (GSH) Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Kaiping Genuine Biochemical Pharmaceutical Reduced Glutathione (GSH) Product Offerings

7.7.5 Kaiping Genuine Biochemical Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Reduced Glutathione (GSH) Industrial Chain

8.2 Reduced Glutathione (GSH) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Reduced Glutathione (GSH) Sales Model

8.5.2 Sales Channel

8.5.3 Reduced Glutathione (GSH) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Reduced Glutathione (GSH) Market Trends

Table 2. Reduced Glutathione (GSH) Market Drivers & Opportunity

Table 3. Reduced Glutathione (GSH) Market Challenges

Table 4. Reduced Glutathione (GSH) Market Restraints

Table 5. Global Reduced Glutathione (GSH) Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Reduced Glutathione (GSH) Revenue Market Share by Company (2020-2025)

Table 7. Global Reduced Glutathione (GSH) Sales Volume by Company (2020-2025) & (K MT)

Table 8. Global Reduced Glutathione (GSH) Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Reduced Glutathione (GSH) Price by Company (2020-2025) & (USD/MT)

Table 10. Key Manufacturers Reduced Glutathione (GSH) Manufacturing Base and Headquarters

Table 11. Key Manufacturers Reduced Glutathione (GSH) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Reduced Glutathione (GSH)

Table 13. Global Reduced Glutathione (GSH) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reduced Glutathione (GSH) as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Reduced Glutathione (GSH) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Reduced Glutathione (GSH) Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Reduced Glutathione (GSH) Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Reduced Glutathione (GSH) Sales Market Share in Value by Type (2020-2025)

Table 20. Global Reduced Glutathione (GSH) Sales Market Share in Value by Type (2026-2031)

Table 21. Global Reduced Glutathione (GSH) Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)

Table 22. Global Reduced Glutathione (GSH) Sales Volume by Type (2020-2025) & (K MT)

Table 23. Global Reduced Glutathione (GSH) Sales Volume by Type (2026-2031) & (K MT)

Table 24. Global Reduced Glutathione (GSH) Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Reduced Glutathione (GSH) Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Reduced Glutathione (GSH) Price by Type (2020-2025) & (USD/MT)

Table 27. Global Reduced Glutathione (GSH) Price by Type (2026-2031) & (USD/MT)

Table 28. Global Reduced Glutathione (GSH) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Reduced Glutathione (GSH) Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Reduced Glutathione (GSH) Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Reduced Glutathione (GSH) Sales Market Share in Value by Application (2020-2025)

Table 32. Global Reduced Glutathione (GSH) Sales Market Share in Value by Application (2026-2031)

Table 33. Global Reduced Glutathione (GSH) Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)

Table 34. Global Reduced Glutathione (GSH) Sales Volume by Application (2020-2025) & (K MT)

Table 35. Global Reduced Glutathione (GSH) Sales Volume by Application (2026-2031) & (K MT)

Table 36. Global Reduced Glutathione (GSH) Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Reduced Glutathione (GSH) Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Reduced Glutathione (GSH) Price by Application (2020-2025) & (USD/MT)

Table 39. Global Reduced Glutathione (GSH) Price by Application (2026-2031) & (USD/MT)

Table 40. Global Reduced Glutathione (GSH) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Reduced Glutathione (GSH) Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Reduced Glutathione (GSH) Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Reduced Glutathione (GSH) Sales Value by Region (2020-2025) & (%)

Table 44. Global Reduced Glutathione (GSH) Sales Value by Region (2026-2031) & (%)

Table 45. Global Reduced Glutathione (GSH) Sales Volume by Region (K MT): 2020 VS 2024 VS 2031

Table 46. Global Reduced Glutathione (GSH) Sales Volume by Region (2020-2025) & (K MT)

Table 47. Global Reduced Glutathione (GSH) Sales Volume by Region (2026-2031) & (K MT)

Table 48. Global Reduced Glutathione (GSH) Sales Volume by Region (2020-2025) & (%)

Table 49. Global Reduced Glutathione (GSH) Sales Volume by Region (2026-2031) & (%)

Table 50. Global Reduced Glutathione (GSH) Average Price by Region (2020-2025) & (USD/MT)

Table 51. Global Reduced Glutathione (GSH) Average Price by Region (2026-2031) & (USD/MT)

Table 52. Key Countries/Regions Reduced Glutathione (GSH) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Reduced Glutathione (GSH) Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Reduced Glutathione (GSH) Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Reduced Glutathione (GSH) Sales Volume, (2020-2025) & (K MT)

Table 56. Key Countries/Regions Reduced Glutathione (GSH) Sales Volume, (2026-2031) & (K MT)

Table 57. Kyowa Hakko Bio Company Information

Table 58. Kyowa Hakko Bio Introduction and Business Overview

Table 59. Kyowa Hakko Bio Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 60. Kyowa Hakko Bio Reduced Glutathione (GSH) Product Offerings

Table 61. Kyowa Hakko Bio Recent Development

Table 62. Sigma-Aldrich Company Information

Table 63. Sigma-Aldrich Introduction and Business Overview

Table 64. Sigma-Aldrich Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 65. Sigma-Aldrich Reduced Glutathione (GSH) Product Offerings

Table 66. Sigma-Aldrich Recent Development

Table 67. Cayman Chemical Company Information

Table 68. Cayman Chemical Introduction and Business Overview

Table 69. Cayman Chemical Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 70. Cayman Chemical Reduced Glutathione (GSH) Product Offerings

Table 71. Cayman Chemical Recent Development

Table 72. Santa Cruz Biotechnology Company Information

Table 73. Santa Cruz Biotechnology Introduction and Business Overview

Table 74. Santa Cruz Biotechnology Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 75. Santa Cruz Biotechnology Reduced Glutathione (GSH) Product Offerings

Table 76. Santa Cruz Biotechnology Recent Development

Table 77. Shandong Jincheng Biological Pharmaceutical Company Information

Table 78. Shandong Jincheng Biological Pharmaceutical Introduction and Business Overview

Table 79. Shandong Jincheng Biological Pharmaceutical Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 80. Shandong Jincheng Biological Pharmaceutical Reduced Glutathione (GSH) Product Offerings

Table 81. Shandong Jincheng Biological Pharmaceutical Recent Development

Table 82. GSH World Company Information

Table 83. GSH World Introduction and Business Overview

Table 84. GSH World Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 85. GSH World Reduced Glutathione (GSH) Product Offerings

Table 86. GSH World Recent Development

Table 87. Kaiping Genuine Biochemical Pharmaceutical Company Information

Table 88. Kaiping Genuine Biochemical Pharmaceutical Introduction and Business Overview

Table 89. Kaiping Genuine Biochemical Pharmaceutical Reduced Glutathione (GSH) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 90. Kaiping Genuine Biochemical Pharmaceutical Reduced Glutathione (GSH) Product Offerings

Table 91. Kaiping Genuine Biochemical Pharmaceutical Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Reduced Glutathione (GSH) Downstream Customers

Table 95. Reduced Glutathione (GSH) Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Reduced Glutathione (GSH) Product Picture

Figure 2. Global Reduced Glutathione (GSH) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Reduced Glutathione (GSH) Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Reduced Glutathione (GSH) Sales Volume (2020-2031) & (K MT)

Figure 5. Global Reduced Glutathione (GSH) Sales Price (2020-2031) & (USD/MT)

Figure 6. Reduced Glutathione (GSH) Report Years Considered

Figure 7. Global Reduced Glutathione (GSH) Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Reduced Glutathione (GSH) Players Sales Volume Ranking (2024) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Reduced Glutathione (GSH) Revenue in 2024

Figure 10. Reduced Glutathione (GSH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Food Grade Picture

Figure 12. Cosmetic Grade Picture

Figure 13. Pharmaceutical Grade Picture

Figure 14. Global Reduced Glutathione (GSH) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Reduced Glutathione (GSH) Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Reduced Glutathione (GSH) Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)

Figure 17. Global Reduced Glutathione (GSH) Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Reduced Glutathione (GSH) Price by Type (2020-2031) & (USD/MT)

Figure 19. Product Picture of Pharmaceuticals

Figure 20. Product Picture of Food Industry

Figure 21. Product Picture of Health Care Products

Figure 22. Product Picture of Other

Figure 23. Global Reduced Glutathione (GSH) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 24. Global Reduced Glutathione (GSH) Sales Value Market Share by Application, 2024 & 2031

Figure 25. Global Reduced Glutathione (GSH) Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)

Figure 26. Global Reduced Glutathione (GSH) Sales Volume Market Share by Application, 2024 & 2031

Figure 27. Global Reduced Glutathione (GSH) Price by Application (2020-2031) & (USD/MT)

Figure 28. North America Reduced Glutathione (GSH) Sales Value (2020-2031) & (US$ Million)

Figure 29. North America Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

Figure 30. Europe Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

Figure 32. Asia Pacific Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Reduced Glutathione (GSH) Sales Value by Region (%), 2024 VS 2031

Figure 34. South America Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 35. South America Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

Figure 36. Middle East & Africa Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 37. Middle East & Africa Reduced Glutathione (GSH) Sales Value by Country (%), 2024 VS 2031

Figure 38. Key Countries/Regions Reduced Glutathione (GSH) Sales Value (%), (2020-2031)

Figure 39. Key Countries/Regions Reduced Glutathione (GSH) Sales Volume (%), (2020-2031)

Figure 40. United States Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 41. United States Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 42. United States Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 43. Europe Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 44. Europe Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 45. Europe Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 46. China Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 47. China Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 48. China Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 49. Japan Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 50. Japan Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 51. Japan Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 52. South Korea Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 53. South Korea Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 54. South Korea Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 55. Southeast Asia Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 56. Southeast Asia Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 57. Southeast Asia Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 58. India Reduced Glutathione (GSH) Sales Value, (2020-2031) & (US$ Million)

Figure 59. India Reduced Glutathione (GSH) Sales Value by Type (%), 2024 VS 2031

Figure 60. India Reduced Glutathione (GSH) Sales Value by Application (%), 2024 VS 2031

Figure 61. Reduced Glutathione (GSH) Industrial Chain

Figure 62. Reduced Glutathione (GSH) Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Reduced Glutathione (GSH) market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Reduced Glutathione (GSH) market is 3.5% 2025 to 2031.

What was the global market size of Reduced Glutathione (GSH) in 2031? shouQi

What was the global market size of Reduced Glutathione (GSH) in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Reduced Glutathione (GSH) market? shouQi

Related Reports

Global Reduced Glutathione (GSH) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Reduced Glutathione (GSH) market size was US$ 149 million in 2025 and is forecast to reach a readjusted size of US$ 189 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 80
USD 4250.00
(Single User License)
Global Reduced Glutathione (GSH) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 189 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 148
USD 4900.00
(Single User License)
Reduced Glutathione (GSH)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 149 million in 2025 and is projected to reach US$ 189 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
Global Reduced Glutathione (GSH) Market Research Report 2026
The global Reduced Glutathione (GSH) market was valued at US$ 149 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 131
USD 2900.00
(Single User License)
Global Reduced Glutathione (GSH) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Reduced Glutathione (GSH) market is projected to grow from US$ 145 million in 2024 to US$ 184 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 149
USD 4900.00
(Single User License)
Global Reduced Glutathione (GSH) Market Insights, Forecast to 2031
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 184 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published Date: 2025-05-25
Pages: 149
USD 4900.00
(Single User License)
Global Reduced Glutathione (GSH) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Reduced Glutathione (GSH) market size was US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-05-25
Pages: 80
USD 4250.00
(Single User License)
Global Reduced Glutathione (GSH) Market Research Report 2025
The global market for Reduced Glutathione (GSH) was valued at US$ 145 million in the year 2024 and is projected to reach a revised size of US$ 184 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-05-25
Pages: 95
USD 2900.00
(Single User License)
Reduced Glutathione (GSH)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 106
USD 3950.00
(Single User License)
Global Reduced Glutathione (GSH) Market Insights, Forecast to 2030
The global Reduced Glutathione (GSH) market is projected to grow from US$ 140.3 million in 2024 to US$ 172.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)

Global Reduced Glutathione (GSH) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Reduced Glutathione (GSH) market size was US$ 149 million in 2025 and is forecast to reach a readjusted size of US$ 189 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 80
USD 4250.00 (Single User License)
Global Reduced Glutathione (GSH) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 189 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 148
USD 4900.00 (Single User License)
Reduced Glutathione (GSH)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 149 million in 2025 and is projected to reach US$ 189 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 108
USD 3950.00 (Single User License)
Global Reduced Glutathione (GSH) Market Research Report 2026
The global Reduced Glutathione (GSH) market was valued at US$ 149 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 131
USD 2900.00 (Single User License)
Global Reduced Glutathione (GSH) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Reduced Glutathione (GSH) market is projected to grow from US$ 145 million in 2024 to US$ 184 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 149
USD 4900.00 (Single User License)
Global Reduced Glutathione (GSH) Market Insights, Forecast to 2031
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 184 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published: 2025-05-25
Pages: 149
USD 4900.00 (Single User License)
Global Reduced Glutathione (GSH) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Reduced Glutathione (GSH) market size was US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-05-25
Pages: 80
USD 4250.00 (Single User License)
Global Reduced Glutathione (GSH) Market Research Report 2025
The global market for Reduced Glutathione (GSH) was valued at US$ 145 million in the year 2024 and is projected to reach a revised size of US$ 184 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-05-25
Pages: 95
USD 2900.00 (Single User License)
Reduced Glutathione (GSH)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 106
USD 3950.00 (Single User License)
Global Reduced Glutathione (GSH) Market Insights, Forecast to 2030
The global Reduced Glutathione (GSH) market is projected to grow from US$ 140.3 million in 2024 to US$ 172.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published: 2024-04-15
Pages: 95
USD 4900.00 (Single User License)